224
Views
24
CrossRef citations to date
0
Altmetric
Original

Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high‐resolution computed tomography

, , , , , , , , & show all
Pages 388-394 | Received 21 Dec 2005, Accepted 19 May 2006, Published online: 12 Jul 2009

References

  • Lamblin C., Bergoin C., Saelens T., Wallaert. Interstitial lung diseases in collagen vascular diseases. Eur Respir J 2001; 18((Suppl 32))69–80
  • Highland K. B., Silver R. M. New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol 2005; 17: 737–45
  • D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty‐eight autopsy cases and fifty‐eight matched controls. Am J Med 1969; 46: 428–40
  • Steen V. D., Owens G. R., Fino G. J., Rodnan G. P., Medsger T. A. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985; 28: 759–67
  • Roschmann R. A., Rothenberg R. J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum 1987; 16: 174–85
  • Fox R. I. Sjögren's syndrome. Lancet 2005; 366: 321–31
  • Constantopoulos S. H., Papadimitriou C. S., Moutsopoulos H. M. Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study. Chest 1985; 88: 226–9
  • Pertovaara M., Korpela M., Saarelainen S., Laitinen J., Jarvenpaa R., Laippala P., et al. Long‐term follow‐up study of pulmonary findings in patients with primary Sjogren's syndrome. Scand J Rheumatol 2004; 33: 343–8
  • Keane M. P., Lynch III J. P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55: 159–66
  • Fenlon H. M., Doran M., Sant S. M., Breatnach E. High‐resolution chest CT in systemic lupus erythematosus. Am J Roentgenol 1996; 166: 301–7
  • Prakash U. B. S. Pulmonary manifestations in mixed connective tissue disease. Semin Resp Med 1988; 9: 318–24
  • Scherak O., Kolarz G., Popp W., Wottawa A., Ritschka L., Braun O. Lung involvement in rheumatoid factor‐negative arthritis. Scand J Rheumatol 1993; 22: 225–8
  • Casserly I. P., Fenlon H. M., Breatnach E., Sant S. M. Lung findings on high‐resolution computed tomography in idiopathic ankylosing spondylitis – correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol 1997; 36: 677–82
  • Zompatori M., Bna C., Poletti V., Spaggiari E., Ormitti F., Calabrò E., et al. Diagnostic imaging of diffuse infiltrative disease of the lung. Respiration 2004; 71: 4–19
  • Wells A. U., Hansell D. M., Corrin B., Harrison N. K., Goldstraw P., Black C. M., et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992; 47: 738–42
  • Wells A. U., Hansell D. M., Rubens M. B., Cullinan P., Black C. M., du Bois R. M. The predictive value of appearances on thin‐section computed thomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148: 1076–82
  • Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
  • Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
  • Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)., Arthritis Rheum. 23. 581–90
  • Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
  • Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218–27
  • Doria A., Ghirardello A., De Zambiasi P., Ruffatti A., Gambari P. F. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992; 19: 259–64
  • American Thoracic Society. Standardization of spirometry: 1994 update., Am J Respir Crit Care Med. 152. 1107–36
  • Warrick J. H., Bhalla M., Schabel S. I., Silver R. M. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991; 18: 1520–8
  • Brennan P., Silman A. Statistical methods for assessing observer variability in clinical measures. Br Med J 1992; 304: 1491–4
  • Klein J., Gamsu G. High resolution computed tomography of diffuse lung disease. Invest Radiol 1989; 24: 805–12
  • Diot E., Boissinot E., Asquier E., Guilmot J. L., Lemarie E., Valat C., et al. Relationship between abnormalities on high‐resolution CT and pulmonary function in systemic sclerosis. Chest 1998; 114: 1623–9
  • Webb W. R. High resolution lung computed tomography. Radiol Clin North Am 1991; 29: 1051–63
  • Mastora I., Remy‐Jardin M., Sobaszek A., Boulenguez C., Remy J., Edme J. L. Thin‐section CT findings in 250 volunteers: assessment of the relationship of CT findings with smoking history and pulmonary function test results. Radiology 2001; 218: 695–702
  • Saag K. G., Kolluri S., Koehnke R. K., Georgou T. A., Rachow J. W., Hunninghake G. W., et al. Rheumatoid arthritis lung disease. Arthritis Rheum 1996; 39: 1711–19
  • Dawson J. K., Fewins H. E., Desmond J., Lynch M. P., Graham D. R. Fibrosing alveolitis in patients with rheumathoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001; 56: 622–7
  • Ganten M., Radeleff B., Kampschulte A., Daniels M. D., Kauffmann G. W., Hansmann J. Comparing image quality of flat‐panel chest radiography with storage phosphor radiography and film‐screen radiography. AJR Am J Roentgenol 2003; 181: 171–6
  • White B., Moore W. C., Wigley F. M., Xiao H. Q., Wise R. A. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 947–54
  • Davas E. M., Peppas C., Maragou M., Albanou E., Hondros D., Dantis C. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma. Clin Rheumatol 1999; 18: 455–61
  • Dawson J. K., Graham D. R., Desmond J., Fewins H. E., Lynch M. P. Investigation of the chronic pulmonary effects of low‐dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology 2002; 41: 262–7
  • Ryu J. H., Colby T. V., Hartman T. E., Vassallo R. Smoking‐related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122–32
  • Nicholson A. G., Colby T. V., du Bois R. M., Hansell D. M., Wells A. U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Resp Crit Care Med 2000; 162: 2213–17
  • Moon J., du Bois R. M., Colby T. V., Hansell D. M., Nicholson A. G. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54: 1009–14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.